Search Ontology:
ChEBI

ZSTK-474

Term ID
CHEBI:90545
Synonyms
  • 1-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-1H-benzimidazole
  • 2-(2-difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine
  • 2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine
  • 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole
  • 4,4'-(6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine
  • ZSTK 474
  • ZSTK474
Definition
A triamino-1,3,5-triazine that is 1,3,5-triazine in which two of the hydrogens have been replaced by morpholin-4-yl groups while the third hydrogen has been replaced by a 2-(difluoromethyl)benzimidazol-1-yl group. It is an inhibitor of phosphatidylinositol 3-kinase.
References
  • cas:475110-96-4
  • lincs.smallmolecule:LSM-1053
  • pdb-ccd:ZS4
  • pubmed:16622124
  • pubmed:17711503
  • pubmed:19094964
  • pubmed:19144509
  • pubmed:19182393
  • pubmed:20081827
  • pubmed:20482767
  • pubmed:20729870
  • pubmed:21352422
  • pubmed:21993922
  • pubmed:22088482
  • pubmed:22349137
  • pubmed:23812078
  • pubmed:24204196
  • pubmed:24297065
  • pubmed:24821574
  • pubmed:24844601
  • pubmed:25483727
  • pubmed:26081844
  • reaxys:11677260
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from ZSTK-474
Phenotype where environments contain ZSTK-474
Phenotype modified by environments containing ZSTK-474
Phenotype affecting ZSTK-474
Human Disease Model